p-values of BT942 compared with vehicle were 0.027 for CD8+T at day 16 after tumor inoculation in early phase, 0.048 for CD4+T and 0.037 for CD8+T at day 24 after tumor inoculation in late phase, respectively (Fig. 5a,b,f,g). This evidence concerns the gene CD8A and neoplasm.